ProPhase Labs Inc (PRPH)
5.42
0.00 (0.00%)
USD |
NASDAQ |
May 06, 10:51
ProPhase Labs Debt to Equity Ratio: 0.2077 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2077 |
| September 30, 2023 | 0.1294 |
| June 30, 2023 | 0.1628 |
| March 31, 2023 | 0.1606 |
| December 31, 2022 | 0.0377 |
| September 30, 2022 | 0.1178 |
| June 30, 2022 | 0.1173 |
| March 31, 2022 | 0.1206 |
| December 31, 2021 | 0.1712 |
| September 30, 2021 | 0.2088 |
| June 30, 2021 | 0.2094 |
| March 31, 2021 | 0.1897 |
| December 31, 2020 | 0.9465 |
| September 30, 2020 | 0.9284 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.2499 |
| September 30, 2016 | 0.2271 |
| June 30, 2016 | 0.2321 |
| March 31, 2016 | 0.1964 |
| December 31, 2015 | 0.166 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.9465
Maximum
Dec 2020
0.1952
Average
0.1294
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0008 |
| XWELL Inc | 0.00 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
| OncoCyte Corp | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 91.93M |
| Total Liabilities (Quarterly) | 42.54M |
| Shareholders Equity (Quarterly) | 49.38M |
| Current Ratio | 2.282 |
| Net Debt Paydown Yield | -0.55% |